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We modified the phosphocellulose binding assay for aminoglycoside-modifying enzymes (AMEs) by use of
microdilution plates and a multichannel micropipette. Batteries of aminoglycoside substrates for screening
organisms for the presence of AMEs as well as for subclassifying enzymes were prepared and stored in
microdilution plates. When tested in parallel with the conventional tube reaction assay, the microplate assay
yielded comparable radioactive counts and therefore equally correct identifications of AMEs in 32 isolates
representing nine bacterial species. Other modifications, such as multichannel dispensing of crude enzyme
preparations and radioisotopic precursors, provided a more rapid, convenient, and less expensive means of
examining large collections of organisms for AMEs.
In pathogenic bacteria, enzymatic modification is the most
common mechanism of resistance to aminoglycosides (AGs)
(1). At least 27 AG-modifying enzymes (AMEs) have been
described, each belonging to one of three classes: acetyl-
transferase (AAC), nucleotidyltransferase (ANT), or phos-
photransferase (APH).
The most reliable method of identifying specific AMEs is
the phosphocellulose binding assay (PBA), described in 1971
by Davies et al., which exploits the affinity of the strongly
basic AGs for negatively charged media (4). If a radiolabeled
moiety is enzymatically attached to a particular AG, radio-
active counts on the paper will be elevated. Enzymes within
any of the three major AME classes may be identified,
depending upon which drugs are capable of serving as
substrates. Although variations in the PBA, such as buffer
composition, preparation of cell-free enzyme extracts, and
other reaction parameters, have been described (3, 7, 8), the
principle of the assay has not changed, and the test proce-
dure has remained cumbersome and time-consuming. Less
cumbersome means of both screening for AMEs and identi-
fying specific enzymes are needed, especially for large
collections of organisms under epidemiologic evaluation.
Advances toward this end were made in 1978 by Drasar, who
proposed the substitution of disposable microtiter plates for
individual serologic tubes in which to perform reactions (7),
and in 1982 by Shannon and Phillips, who suggested that
AMEs can be screened by using only one or two AG
substrates rather than the complete battery necessary for
subclassifying enzymes (11). These screening methods are
possible since the majority of enzymes within a class share
common substrates. Gentamicin, tobramycin, or both, for
example, are modified by all AACs described to date.
The purpose of our study was to develop a more conven-
ient microdilution plate PBA for both screening for AMEs
and subclassifying enzymes.
MATERIALS AND METHODS
Organisms. Five strains of Pseudomonas aeruginosa used
as AME-positive controls were supplied by the Mechanisms
* Corresponding author.
of Resistance Service, Bristol Laboratories, Syracuse, N.Y.
I Also tested were 27 bacterial isolates (see Table 3) which
I represented five gram-negative species (three genera) and
three Staphylococcus species. These isolates were obtained
from hospitals and were resistant to at least one AG.
Cell-free lysates of gram-negative bacilli were prepared as
follows. Brain heart infusion broth (200 ml in a 500-ml flask)
was inoculated with 20 ml of an overnight broth culture and
incubated with shaking at 35°C until the late exponential
growth phase was reached (usually 4 to 5 h). Cells were
harvested by centrifugation, washed twice in 10 ml of cold
0.01 M Tris-0.03 M NaCl (pH 7.8), and suspended in 6 ml of
cold 0.3 M Tris-maleate-0.03 M MgCl2-0.01 M dithiothreitol
(pH 7.8). Suspensions were sonicated twice (1 min each with
constant ice-ethanol cooling) with a W-375 sonic disruptor
equipped with a tapered microtip probe (Heat Systems-
Ultrasonics, Plainview, N.Y.), followed by centrifugation
for 15 min at 12,000 x g and 4°C to remove cellular debris.
Modifications for staphylococci included an alternative
broth (Trypticase soy broth [BBL Microbiology Systems,
Cockeysville, Md.] containing 0.5% glycine and 0.3% yeast
extract), cellular washes in 0.01 M Tris-0.01 M MgCl2-0.05
M NH4Cl-0.005 M P-mercaptoethanol (pH 7.8), and treat-
ment with lysostaphin (50 to 100 ,ug/ml for 30 to 60 min at
35°C). Staphylococcal cells were suspended in 3 ml of
washing buffer and sonicated for 30 s. Cell-free lysates were
stored at - 70°C for no more than 1 year (2 months for
staphylococci) in 1-ml aliquots which were discarded after
being thawed and tested.
Reagents. Stock radioisotopes included [1-14C]acetyl co-
enzyme A (10 ,Ci/ml; 40 to 60 ,uCi/,umol; ICN Biomedicals
Inc., Irvine, Calif.), [U-14C]ATP (50 p.Ci/ml; 482 p.Ci/imol;
Amersham Corp., Arlington Heights, Ill.), and [-y-32P]ATP
(10 mCi/ml; 2,900 mCi/,umol; New England Nuclear Corp.,
Boston, Mass.). With the exception of [-y-32P]ATP, working
isotope stocks were prepared and stored as described in
Table 1. Owing to the short half-life of 32p, the volume of
[y-32P]ATP necessary to obtain 25 p.Ci/ml in 0.001 M unla-
beled ATP was calculated, and the working stock was
freshly prepared on the day of the assay. Substrate AGs
were supplied by Bristol Laboratories (amikacin, butirosin,
kanamycin, lividomycin, and paromomycin), Schering
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TABLE 1. Modified PBA for AMEs
Requirementa for indicated assay
Component Step or APH _ANT _AACdescription APH ANT AAC
Advance preparation
Substratesa 1. Dilute in distilled H20
2. Dispense into microdilution plates,
store at -70°C
10 ,ul (250 p.g/ml)
1. Sonic extract (see text)
2. Store at -70°C
1. Dilute






(5 ,uCi/,umol per ml)
A (0.3 M Tris, 0.3 M maleic acid, B
0.03 M MgCl2, 0.01 M
dithiothreitol [pH 7.8])
B (0.066 M Tris [pH 7.8], 0.033 M
MgCl2, 0.033 M NH4Cl, 0.0016 M
dithiothreitol)
1. Sheets measuring 60 by 120 mm
2. 12 Numbered sections
1. Dilute in buffer





1. Incubate (30 min at 35°C)
2. Return to ice
3. Spot onto P81 paper 20 p.1
4. Air dry (30 s)
5. Stop reaction (1 liter of distilled
H20, 80°C, 2 min)
6. Wash (three times in 500 ml of
distilled H20)
7. Dry (e.g., heat lamp)
1. Divide P81 into numbered sections
2. Place into vials containing 7 ml of
scintillant
3. Count for 1 min on proper 0-670
scintillation window
a See Table 2.
b Stored at 4°C.
c Maintained on ice.
Corp., Kenilworth, N.J. (gentamicin C, C1, and ClA; netil-
micin, and sisomicin), The Upjohn Co., Kalamazoo, Mich.
(neomycin and spectinomycin), Pfizer Inc., New York, N.Y.
(streptomycin), and Eli Lilly & Co., Indianapolis, Ind.
(tobramycin). Substrates (Table 2) were prepared as shown
in Table 1, dispensed into microdilution plates (Dynatech
Laboratories, Inc., Alexandria, Va.) by using a Titertek
12-channel variable-volume micropipette (Flow Laborato-
ries, Inc., McLean, Va.), and stored at - 70°C. Phospho-
cellulose paper (Whatman P81) was obtained from VWR
Scientific, San Francisco, Calif.
Enzyme assays. Microdilution plate assays for AMEs were
performed as described in Table 1. Isotopes, followed by
lysates, were dispensed at the time of the assay into micro-
dilution plates containing substrates. Spotting of reaction
mixtures required elevating the phosphocellulose (we used
straight pins), using only four equally spaced tips on the
multichannel micropipette, and altering the numbering on
the paper to correlate with microdilution wells (e.g., wells 1,
4, 7, and 10 on the top one-third of the paper, wells 2, 5, 8,
and 11 on the middle one-third, and wells 3, 6, 9, and 12 on
the bottom one-third). Conventional AME assays were also
performed as described in Table 1, with the following
substitutions. Borosilicate glass tubes (10 by 75 mm), rather
than microdilution plates, were used for the reactions. All
the components, including the substrates, were dispensed on
the day of the assay by using a single-channel micropipette
(Gilson Pipetman; Rainin Instrument Co., Woburn, Mass.).
Reaction mixtures were spotted individually onto pieces of
phosphocellulose (numbered and cut to approximately 1 cm2
before the assay).
Screening assays were performed by the microplate pro-
cedure as described in Table 1 except that fewer substrates
were tested for each class. Each cell-free lysate was evalu-
ated in a single row (12 wells) of a microplate which
contained isotopes, water controls, and the substrates nec-
essary for identifying AMEs to the class level (Table 2).
For all procedures, a substrate was regarded to be modi-
Lysates
Isotopes
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TABLE 2. Substrates used in AME microplate assays
Substratea used in microplate well:
Class
1 2 3 4 5 6 7 8 9 10 11 12
AAC H20 K N TM AN GM SIS NET BUT PAR C1 CIA
ANT H20 K N TM AN GM BUT PAR S SPT
APH H20 K N TM AN GM SIS BUT LIV S SPT
a There were eight identical substrate batteries per 96-well plate. Abbreviations for aminoglycosides: AN, amikacin; BUT, butirosin; GM, gentamicin C; C1 and
CIA, gentamicin C subfractions; K, kanamycin; LIV, lividomycin; N, neomycin; NET, netilmicin; PAR, paromomycin; SIS, sisomicin; SPT, spectinomycin; S,
streptomycin; and TM, tobramycin. For screening assays, H20, GM, and TM were used for AAC, H20, K, N, SPT, and S were used for APH, and H20, K, S,
and SPT were used for ANT.
fied if radioactive counts were greater than or equal to five
times those of water controls (no AG). Subclassification of
enzymes was done by using previously described interpre-
tive tables (1, 3, 6, 11).
RESULTS
Tests for subclassifying AMEs (conventional and micro-
plate assays) were performed with all 32 isolates (Table 3).
At least one AME was detected in 30 isolates, and 19
produced more than one enzyme. The most common class
was ANT, for which five subclasses were detected among 24
isolates, followed by APH (four subclasses among 17 iso-
lates) and AAC (one subclass among 7 isolates). Patterns of
modification enabled subclassification of all the enzymes,
with the exception of the 3'-APHs detected in five isolates
(two isolates of Acinetobacter calcoaceticus and one isolate
each of "Salmonella infantis," Salmonella typhimurium,
and Klebsiella pneumoniae). These enzymes, designated 3',
5"-APH, could not be further subtyped (e.g., I, II, or III)
since butirosin and lividomycin but not amikacin were
modified, revealing a pattern not ascribable to a single
3'-APH. Agreement of the results obtained from microplate
and conventional assays was complete. For microplate as-
says, radioactive counts of modified substrates were approx-
TABLE 3. Identification of AMEs by standard and microplate PBAs
Subclass(es) determined by indicated assaya
Species Class(es)
determined No. of
AAC ANT APHby screening isolates
MP S MP S MP S
Pseudomonas ANT, APH 2 2" 2" 3' (II) 3' (II)
aeruginosa ANT, APH 1 3", 9 3", 9 3' (II) 3' (II)
AAC,APH 1 6' 6' 3'(11) 3' (II)
APH 1 3' (II) 3' (II)
Acinetobacter ANT, APH 2 3", 9 3", 9 3', 5" 3', 5"
calcoaceticus ANT 2 3", 9 3", 9
No enzyme 2
Salmonella ANT 6 2"+ 3", 2"+3", 9
enteritidis 9
"Salmonella APH 1 3', 5" 3', 5"
infantis"
Salmonella APH 1 3', 5" 3', 5"
typhimurium
Klebsiella APH 1 3', 5" 3', 5"
pneumoniae
Staphylococcus ANT 3 4', 4" 4', 4"
aureus ANT 1 3" 3"
(methicillin APH 1 3' (IV) 3' (IV)
resistant) AAC, ANT 1 6' 6' 4', 4" 4', 4"
ANT, APH 1 6 6 3' (IV) 3' (IV)
AAC,ANT,APH 1 6' 6' 6 6 3' (IV) 3' (IV)
AAC,ANT,APH 1 6' 6' 4', 4" 4', 4" 2" 2"
Staphylococcus AAC,ANT,APH 2 6' 6' 4', 4" 4', 4" 2" 2"
epidermidis
Staphylococcus AAC,ANT,APH 1 6' 6' 4', 4" 4', 4" 2"+3' (IV) 2"+3' (IV)
hominis
a MP, Microdilution plate PBA; S, standard PBA. Entries refer to the site(s) (carbon) of modification on the AG molecule (e.g., 3', 5" means that C-3 on the
'ring and C-5 on the" ring were modified).
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TABLE 4. Comparison of costs of performing microplate and conventional assays for APHSSa
Cost (quantity) [avg unit cost] of:
Reaction ingredients Tubes Scintil-
Isotope (glass; Micro- Micro- P81 paper lation
Assay AG ([32P]ATP) Scintillant Isotope 0-001 Lysate 10 by plates pipette P8M2e vialo Laborb(mg) (,uCi) (ml) buffer M (ml) 75 mm) (n) tips (m) vials (h)
[7.40/gI [465.00/ [10.00/ (ml) ATP (m) 75m) (n)00 tips (n) [5.00/ (n) [10.45/h]
ci
40g46.0 [0liter] [2.91/ (Ml) [31.60/ () [615.00/ [40.00/ 2,622 cm2] [80.00/mCi] ~~~~~~liter] [4.30/g] liter] [2325 10] 1,00 500]
Conven- 0.185 12.79 7.70 0.003 0.003 0.07 2.53 5.20 0.47 17.60 33.96
tional (25.0) (27.5) (770) (1.1) (1.1) (2.2) (110) (130) (248) (110) (3.25)
Micro- 0.185 12.79 7.70 0.003 0.003 0.07 1.30 9.20 1.05 17.60 15.67
plate (25.0) (27.5) (770) (1.1) (1.1) (2.2) (2; 110 (230) (550) (110) (1.5)
wells)
a The PBA for APHs tests each of 10 lysates against 10 AGs and one water control. Costs are given in dollars. Total costs: conventional, 80.51; microplate,
65.57.
b Federally employed GS-9 laboratory microbiologist.
imately equal to those obtained from conventional assays
when expressed as multiples of background counts (water
controls).
Microplate screening was performed blindly by using lysates
assigned a cryptic number to avoid the identification of iso-
lates. AMEs were correctly identified (to the class level) by this
assay when the 32 isolates were tested (Table 3).
A cost comparison for microplate and conventional assays
is shown in Table 4. Costs of materials and reagents were
obtained from 1985 commercial retail catalogs and in some
instances required averaging, owing to variations in prices
among suppliers and units of issue. The performance of 10
APH assays by the microplate, as opposed to the conven-
tional, method cost $14.94 less. While the costs of materials
and reagents were slightly higher, the performance of
microplate assays required substantially less time, with an
estimated labor cost savings of $18.29. Two steps in which
the greatest time savings were realized included predispens-
ing of substrates and spotting of reaction mixtures, both of
which were facilitated by a multichannel micropipette. Once
substrate stocks were prepared, 50 or more plates could be
prepared in 15 min or less.
DISCUSSION
The convenient identification of mechanisms of resistance
is becoming an important component in investigating out-
breaks of drug-resistant organisms. Examples of this tech-
nology are the chromogenic cephalosporin test for 13-
lactamase (9) and, more recently, nucleic acid probes
specific for genes encoding resistance mechanisms (2, 10,
12). The modified PBA may prove especially useful, since
laboratories involved in epidemiologic studies of AG resist-
ance may screen organisms for the presence of AMEs in
microdilution plates. Predispensing of substrates and
multichannel pipetting further streamline the performance of
the assay without sacrificing sensitivity or accuracy.
Unlike 1-lactamases, which may be detected without
extraction due to secretion or spontaneous autolysis, detec-
tion of AMEs continues to require more rigorous lysis
procedures. Although not evaluated in the present study,
this phase of the assay may also be facilitated, for example,
through the use of "mini-preps" which may be obtained
from colony suspensions but which nonetheless still require
lysis techniques such as osmotic shock or sonication. An-
other possible variation is that substrate batteries may be
altered from those described in this study. These changes are
most often related to the availability of various AGs and to
the extent of substrate profiling required. The addition of
apramycin, for example, may be needed for more in-depth
characterization of enzymes that acetylate carbon-3
hydroxyl moieties (5). Screening plates may also be altered
so that, in a single microdilution plate, more isolates may be
tested against fewer substrates. By using three substrates
and one water control in a typical ANT screen, for example,
one may evaluate as many as 24 isolates (three different
lysates in each of eight rows) in a single plate, but for this
class only.
The costs of performing AME assays, of importance
primarily within laboratories in which they are routinely
performed, would be expected to decrease as more assays
are performed, owing to improvements in technical skills
and decreases in costs of materials when purchased in bulk
quantities. Although cost analyses of AAC and ANT assays
were not performed in this study, it can be assumed that
savings would approximate those observed for the APH
assay.
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